Encompassing all aspects of synthetic and biological macromolecules, and related emerging areas
Impact Factor 5.231 24 Issues per Year
Review Article

FDA-approved poly(ethylene glycol)–protein conjugate drugs

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Department of Chemistry & Biochemistry and the California NanoSystems Institute, University of California, 607 Charles E. Young Dr East, Los Angeles, USA
E-mail: maynard@chem.ucla.edu
b
Ronald Reagan UCLA Medical Center, Division of Cardiology, 757 Westwood Plaza, Los Angeles, USA
E-mail: abaas@mednet.ucla.edu
Polym. Chem., 2011,2, 1442-1448

DOI: 10.1039/C1PY00034A
Received 21 Jan 2011, Accepted 20 Mar 2011
First published online 27 Apr 2011

This article is part of themed collection: Polymer Bioconjugates
| | | | | | More
Please wait while Download options loads
Download Citation